摘要
甲型流感病毒M2蛋白是一种具有离子通道功能的跨膜蛋白,其氨基酸序列非常保守,可用于流感通用疫苗的研究。为了构建可调控的稳定表达甲型流感病毒M2蛋白的哺乳动物细胞系,首先应用PCR方法从含有流感病毒PR8株第七节段全长基因的质粒中扩增得到M2基因。将该片段亚克隆到真核表达载体pcDNA5/FRT/TO上,用BamHⅠ和NotⅠ双酶切鉴定正确后将重组质粒与表达Flp重组酶的pOG44质粒共转染Flp-In T-REx-293细胞,使目的基因整合到宿主细胞染色体。筛选具有Hygromycin B抗性的细胞株。在该细胞的培养基中加入四环素以诱导目的基因表达,48 h后通过间接免疫荧光方法检测到M2蛋白的表达。共得到16株高表达M2蛋白的重组细胞株,这些细胞株在传10代后仍能稳定表达目的蛋白。未加四环素诱导的细胞没有检测到M2蛋白,说明四环素调控系统严格控制着目的基因的表达。今后,该细胞系可用于流感病毒M2蛋白的功能研究、流感候选疫苗的免疫学评价以及流感病毒减毒活疫苗的研制。
Matrix protein 2(M2) is an integral tetrameric membrane protein of influenza A virus,which functions as ion channel.M2 sequence has shown remarkable conservation,so there has been growing interest in it as "universal" vaccine.In order to establish a stable 293 cell line that express M2 protein under the control of the tetracycline operator,M2 gene was obtained by PCR amplification from the plasmid containing the segment 7 of influenza A virus strain A/PR/8/34 firstly.The PCR product was cloned into BamH Ⅰ /NotⅠ restriction site of pcDNA5/FRT/TO vector,and cotransfected with pOG44 which express Flp recombinase into Flp-In T-REx-293 cell.Integration of pcDNA5/FRT/TO-M2 into the cell genome at the Flp Recombination 748 ISSN1000-3061 CN11-1998/Q Chin J Biotech May 25,2011 Vol.27 No.5 Target(FRT) site brought the SV40 promoter and the initiation codon in frame with the hygromycin resistance gene.Thus,stable cell lines were selected for hygromycin resistance.The expression of M2 protein from hygromycin-resistant cell was induced by addition of tetracycline into the cell culture media,and then tested by indirect immunofluorescence assay(IFA).16 strains with high expression of M2 were selected.After subculturing for more than ten passages,the cell lines still stably expressed M2 protein.No M2 protein could be detected without tetracycline induction,suggesting that the expression was strictly controlled by tetracycline operator.The cell lines expressing M2 will be useful for further functional studies of M2 protein,detection of immune response against natural structure M2 protein and development of live attenuated influenza virus vaccine with reverse genetics technique.
出处
《生物工程学报》
CAS
CSCD
北大核心
2011年第5期747-754,共8页
Chinese Journal of Biotechnology
基金
"艾滋病和病毒性肝炎等重大传染病防治"科技重大专项(No.2009ZX10004-710)资助~~